Clinical Trial Update: MeFirst: A Tailored Intervention to HPV Vaccine Decision Making [NA]

View source ↗

Summary

This entry reports the completion of the MeFirst trial, a tailored intervention intended to improve decision making about HPV vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus-related Carcinoma

Snippet

Sponsor: University of Michigan | Conditions: Human Papillomavirus-Related Carcinoma | NA | Status: COMPLETED